Virginia M. Diavolitsis

Radiation Oncology

3535 Olentangy River Rd
Columbus, OH 43214

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Financial Toxicity of Shorter Versus Longer Partial Breast Irradiation: A Randomized Clinical Trial.

Financial Toxicity of Shorter Versus Longer Partial Breast Irradiation: A Randomized Clinical Trial.

Journal: International journal of radiation oncology, biology, physics

Published: February 13, 2026

Financial Toxicity of Shorter Versus Longer Partial Breast Irradiation: A Randomized Clinical Trial.

Financial Toxicity of Shorter Versus Longer Partial Breast Irradiation: A Randomized Clinical Trial.

Journal: International journal of radiation oncology, biology, physics

Published: February 13, 2026

A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).

A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).

Journal: Cancer

Published: September 05, 2025

Just Radiate.

Just Radiate.

Journal: International journal of radiation oncology, biology, physics

Published: January 20, 2023

Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study.

Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study.

Journal: Technical innovations & patient support in radiation oncology

Published: August 01, 2021

A series of typical and atypical cases of Bazex syndrome: Identifying the red herring to avoid delaying cancer treatment.

A series of typical and atypical cases of Bazex syndrome: Identifying the red herring to avoid delaying cancer treatment.

Journal: Clinical case reports

Published: March 12, 2020

Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy.

Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy.

Journal: Head & neck

Published: November 10, 2019

Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.

Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.

Journal: International journal of cancer

Published: May 29, 2019

A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.

A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.

Journal: Investigational new drugs

Published: June 04, 2018

Effect of adjuvant radiotherapy treatment center volume on overall survival.

Effect of adjuvant radiotherapy treatment center volume on overall survival.

Journal: Oral oncology

Published: October 27, 2017

Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma.

Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma.

Journal: Oral oncology

Published: October 26, 2017

Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer.

Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer.

Journal: The Laryngoscope

Published: December 22, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026